GB9316895D0
(en)
*
|
1993-08-13 |
1993-09-29 |
Guy S And St Thomas Hospitals |
Hepatoselective insulin analogues
|
US6342225B1
(en)
|
1993-08-13 |
2002-01-29 |
Deutshces Wollforschungsinstitut |
Pharmaceutical active conjugates
|
US6869930B1
(en)
*
|
1993-09-17 |
2005-03-22 |
Novo Nordisk A/S |
Acylated insulin
|
DE4437604A1
(de)
*
|
1994-10-21 |
1996-04-25 |
Basf Ag |
Konjugate aus einem Poly- oder Oligopeptid und einer niedermolekularen lipophilen Verbindung
|
US5646242A
(en)
|
1994-11-17 |
1997-07-08 |
Eli Lilly And Company |
Selective acylation of epsilon-amino groups
|
US5693609A
(en)
*
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
DE69629210T2
(de)
*
|
1995-03-17 |
2004-04-22 |
Novo Nordisk A/S |
Insulinabkömmlinge
|
US6251856B1
(en)
|
1995-03-17 |
2001-06-26 |
Novo Nordisk A/S |
Insulin derivatives
|
US20010041786A1
(en)
*
|
1995-06-07 |
2001-11-15 |
Mark L. Brader |
Stabilized acylated insulin formulations
|
GB9513967D0
(en)
*
|
1995-07-08 |
1995-09-06 |
Univ Leicester |
Insulin
|
US6451970B1
(en)
|
1996-02-21 |
2002-09-17 |
Novo Nordisk A/S |
Peptide derivatives
|
RU2182015C2
(ru)
*
|
1996-06-20 |
2002-05-10 |
Ново Нордиск А/С |
ПРЕПАРАТ ИНСУЛИНА, СОДЕРЖАЩИЙ NaCl, ПАРЕНТЕРАЛЬНАЯ ГОТОВАЯ ФОРМА, СПОСОБ ПОВЫШЕНИЯ ХИМИЧЕСКОЙ СТАБИЛЬНОСТИ ПРЕПАРАТА ИНСУЛИНА
|
AU3255297A
(en)
*
|
1996-07-11 |
1998-02-09 |
Novo Nordisk A/S |
Selective acylation method
|
US5905140A
(en)
*
|
1996-07-11 |
1999-05-18 |
Novo Nordisk A/S, Novo Alle |
Selective acylation method
|
US20020025933A1
(en)
*
|
1996-08-30 |
2002-02-28 |
Knudsen Liselotte Bjerre |
GLP-2 derivatives
|
US6268343B1
(en)
|
1996-08-30 |
2001-07-31 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US6458924B2
(en)
|
1996-08-30 |
2002-10-01 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US7235627B2
(en)
|
1996-08-30 |
2007-06-26 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US5898067A
(en)
*
|
1997-02-07 |
1999-04-27 |
Novo Nordisk A/S |
Crystallization of proteins
|
US6310038B1
(en)
*
|
1997-03-20 |
2001-10-30 |
Novo Nordisk A/S |
Pulmonary insulin crystals
|
US6043214A
(en)
*
|
1997-03-20 |
2000-03-28 |
Novo Nordisk A/S |
Method for producing powder formulation comprising an insulin
|
JP3764174B2
(ja)
*
|
1997-03-20 |
2006-04-05 |
ノボ ノルディスク アクティーゼルスカブ |
肺用組成物において使用するための亜鉛非含有のインスリン結晶
|
US6451762B1
(en)
|
1997-10-24 |
2002-09-17 |
Novo Nordisk A/S |
Aggregates of human insulin derivatives
|
US6444641B1
(en)
|
1997-10-24 |
2002-09-03 |
Eli Lilly Company |
Fatty acid-acylated insulin analogs
|
ZA989644B
(en)
*
|
1997-10-24 |
2000-04-25 |
Lilly Co Eli |
Insoluble insulen compositions.
|
IL134901A0
(en)
|
1997-10-24 |
2001-05-20 |
Lilly Co Eli |
Insoluble insulin compositions
|
ZA989744B
(en)
*
|
1997-10-31 |
2000-04-26 |
Lilly Co Eli |
Method for administering acylated insulin.
|
EP1396272A1
(fr)
*
|
1997-12-23 |
2004-03-10 |
Eli Lilly & Company |
Compositions insolubles d'insuline pour le contrôle du glucose sanguin
|
US6531448B1
(en)
|
1997-12-23 |
2003-03-11 |
Eli Lilly And Company |
Insoluble compositions for controlling blood glucose
|
DE69924232D1
(de)
*
|
1998-01-09 |
2005-04-21 |
Novo Nordisk As |
Stabilisierte insulin-zubereitungen
|
JP2002504527A
(ja)
*
|
1998-02-27 |
2002-02-12 |
ノボ ノルディスク アクティーゼルスカブ |
部分的に組織化したミセル様凝集物を形成する25%を越えるヘリックス成分を有するglp−2誘導体
|
DE19825447A1
(de)
*
|
1998-06-06 |
1999-12-09 |
Hoechst Marion Roussel De Gmbh |
Neue Insulinanaloga mit erhöhter Zinkbildung
|
WO1999065941A1
(fr)
*
|
1998-06-12 |
1999-12-23 |
Kings College London |
Analogue de l'insuline
|
US7169889B1
(en)
*
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
ES2266187T3
(es)
|
2000-03-24 |
2007-03-01 |
Genentech, Inc. |
Uso de la insulina para el tratamiento de trastornos del cartilago.
|
JP2003532691A
(ja)
*
|
2000-05-05 |
2003-11-05 |
ノボ ノルディスク アクティーゼルスカブ |
重症疾患神経障害
|
US7316999B2
(en)
|
2000-06-02 |
2008-01-08 |
Novo Nordisk A/S |
Glucose dependent release of insulin from glucose sensing insulin derivatives
|
WO2002004515A1
(fr)
*
|
2000-07-10 |
2002-01-17 |
Btg International Limited |
Derives d'insuline et synthese desdits derives
|
KR20030005204A
(ko)
*
|
2000-12-25 |
2003-01-17 |
가부시키가이샤 시세이도 |
교감신경 활성화 향료 조성물
|
US7060675B2
(en)
*
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
US6867183B2
(en)
*
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US6653492B2
(en)
|
2001-05-02 |
2003-11-25 |
Novo Nordick A/S |
Preparation of bile acids
|
EP1698636A1
(fr)
*
|
2001-05-02 |
2006-09-06 |
Novo Nordisk A/S |
Procédé de préparation de conjagates de peptides avec des acides biliaire
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7713932B2
(en)
*
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
US6858580B2
(en)
*
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828297B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6713452B2
(en)
*
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6835802B2
(en)
*
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US7595172B2
(en)
|
2001-07-24 |
2009-09-29 |
Novo Nordisk A/S |
Method for making acylated polypeptides
|
MXPA04001560A
(es)
|
2001-08-28 |
2004-05-17 |
Lilly Co Eli |
Premezclas de glp-1 e insulina basal.
|
US7176278B2
(en)
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
MY127575A
(en)
|
2001-09-07 |
2006-12-29 |
Biocon Ltd |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US6913903B2
(en)
*
|
2001-09-07 |
2005-07-05 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7312192B2
(en)
*
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7166571B2
(en)
*
|
2001-09-07 |
2007-01-23 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7196059B2
(en)
*
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
EP2243776A1
(fr)
|
2001-10-12 |
2010-10-27 |
High Point Pharmaceuticals, LLC |
Piperidines substituées et leur utilisation dans le traitement de maladies liées au recepteur histaminique H3
|
WO2003035099A1
(fr)
|
2001-10-19 |
2003-05-01 |
Eli Lilly And Company |
Melanges biphasiques de glp-1 et d'insuline
|
DE60236014D1
(de)
|
2001-11-19 |
2010-05-27 |
Novo Nordisk As |
Verfahren zur herstellung von insulinverbindungen
|
GB0206792D0
(en)
|
2002-03-22 |
2002-05-01 |
Leuven K U Res & Dev |
Normoglycemia
|
ES2360182T3
(es)
*
|
2002-05-07 |
2011-06-01 |
Novo Nordisk A/S |
Formulaciones solubles que comprenden insulina monomérica e insulina acilada.
|
US20040038864A1
(en)
*
|
2002-06-27 |
2004-02-26 |
Per Balschmidt |
Use of dimethyl sulfone as isotonicity agent
|
KR101131783B1
(ko)
*
|
2002-09-25 |
2012-03-30 |
노보 노르디스크 에이/에스 |
아실화된 펩타이드의 제조방법
|
US7273921B2
(en)
|
2002-09-25 |
2007-09-25 |
Novo Nordisk A/S |
Method for producing acylated peptides
|
WO2004035624A2
(fr)
|
2002-10-14 |
2004-04-29 |
Novo Nordisk A/S |
Composes glp-2, leurs formulations et leurs utilisations
|
US20040138099A1
(en)
*
|
2002-11-29 |
2004-07-15 |
Draeger Eberhard Kurt |
Insulin administration regimens for the treatment of subjects with diabetes
|
WO2004085472A1
(fr)
*
|
2003-03-27 |
2004-10-07 |
Novo Nordisk A/S |
Procede de fabrication de precurseurs de l'insuline humaine et insuline humaine
|
JP4629657B2
(ja)
|
2003-04-11 |
2011-02-09 |
ハイ・ポイント・ファーマスーティカルズ、エルエルシー |
11β−ヒドロキシステロイドデヒドロゲナーゼ1型化活性化合物
|
WO2004096266A1
(fr)
*
|
2003-05-02 |
2004-11-11 |
Novo Nordisk A/S |
Stabilite physique amelioree de preparations d'insuline
|
RU2381103C2
(ru)
|
2003-06-27 |
2010-02-10 |
Ново Нордиск А/С |
Контейнер для жидких фармацевтических композиций с высокими влагозащитными свойствами
|
JP4463814B2
(ja)
|
2003-08-05 |
2010-05-19 |
ノボ ノルディスク アクティーゼルスカブ |
新規のインスリン誘導体
|
EP2264066A3
(fr)
|
2003-08-05 |
2011-07-27 |
Novo Nordisk A/S |
Nouveaux derives de l'insuline
|
JP2007532096A
(ja)
|
2003-11-14 |
2007-11-15 |
ノボ ノルディスク アクティーゼルスカブ |
アシル化されたインスリンの製造方法
|
ES2727854T3
(es)
|
2003-11-20 |
2019-10-21 |
Novo Nordisk As |
Formulaciones de péptidos que contienen propilenglicol que son óptimas para la producción y para su uso en dispositivos de inyección
|
AU2004295023A1
(en)
|
2003-12-03 |
2005-06-16 |
Novo Nordisk A/S |
Single-chain insulin
|
ATE483580T1
(de)
|
2003-12-22 |
2010-10-15 |
Novo Nordisk As |
Durchsichtiger, flexibler, undurchlässiger kunststoffbehälter zur lagerung von pharmazeutischen flüssigkeiten
|
CN1909930B
(zh)
|
2004-01-21 |
2015-12-16 |
诺和诺德医疗保健公司 |
转谷氨酰胺酶介导的肽的接合
|
PT2319500E
(pt)
*
|
2004-03-12 |
2013-01-23 |
Biodel Inc |
Composições de distribuição de fármacos de actuação rápida
|
WO2006008238A1
(fr)
*
|
2004-07-16 |
2006-01-26 |
Novo Nordisk A/S |
Procede d'acylation selective
|
US7872095B2
(en)
*
|
2004-07-19 |
2011-01-18 |
Biocon Limited |
Insulin-oligomer conjugates, formulations and uses thereof
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
WO2006082204A1
(fr)
|
2005-02-02 |
2006-08-10 |
Novo Nordisk A/S |
Derives d'insuline
|
EP2292653B1
(fr)
|
2005-02-02 |
2014-05-21 |
Novo Nordisk A/S |
Nouveaux dérivés d'insuline
|
JP5235661B2
(ja)
|
2005-05-25 |
2013-07-10 |
ノボ・ノルデイスク・エー/エス |
安定化ポリペプチド製剤
|
JP2008542235A
(ja)
*
|
2005-05-25 |
2008-11-27 |
ノボ・ノルデイスク・エー/エス |
安定化ポリペプチド製剤
|
EP1888104A2
(fr)
*
|
2005-05-26 |
2008-02-20 |
Novo Nordisk A/S |
Insuline acylee tres pure
|
WO2007003604A2
(fr)
|
2005-07-04 |
2007-01-11 |
Novo Nordisk A/S |
Medicaments
|
WO2007015805A1
(fr)
|
2005-07-20 |
2007-02-08 |
Eli Lilly And Company |
Composés joints en position 1-amino
|
US9056921B2
(en)
|
2005-08-16 |
2015-06-16 |
Novo Nordisk A/S |
Method for making mature insulin polypeptides
|
US7741281B2
(en)
*
|
2005-11-03 |
2010-06-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
PT1951658E
(pt)
|
2005-11-17 |
2012-11-12 |
Lilly Co Eli |
Antagonistas do receptor do glucagon, preparação e utilizações terapêuticas
|
CN101389650B
(zh)
|
2005-12-28 |
2012-10-10 |
诺沃-诺迪斯克有限公司 |
包含酰化胰岛素和锌的组合物以及制备所述组合物的方法
|
JP5242415B2
(ja)
*
|
2006-01-18 |
2013-07-24 |
フォアシーエイサー ファーマシューティカルズ インコーポレイテッド |
高い安定性を持つ薬理組成物
|
ATE482977T1
(de)
|
2006-02-27 |
2010-10-15 |
Novo Nordisk As |
Insulinderivate
|
WO2007104737A1
(fr)
*
|
2006-03-13 |
2007-09-20 |
Novo Nordisk A/S |
Insuline monocaténaire acylée
|
EP2241327A1
(fr)
|
2006-03-15 |
2010-10-20 |
Novo Nordisk A/S |
Melange d'amyline et d'insuline
|
ES2388681T3
(es)
|
2006-03-28 |
2012-10-17 |
High Point Pharmaceuticals, Llc |
Benzotiazoles con actividad de los receptores de histamina H3
|
CA2649111C
(fr)
|
2006-04-24 |
2013-09-10 |
Eli Lilly And Company |
Pyrrolidinones substtuees a la cyclohexyle comme inhibiteurs de la 11-beta-hydroxysteroide dehydrogenase de type 1
|
US8796205B2
(en)
|
2006-05-09 |
2014-08-05 |
Novo Nordisk A/S |
Insulin derivative
|
CN101437849B
(zh)
*
|
2006-05-09 |
2015-09-30 |
诺沃-诺迪斯克有限公司 |
胰岛素衍生物
|
WO2007128817A2
(fr)
*
|
2006-05-09 |
2007-11-15 |
Novo Nordisk A/S |
Dérivé insulinique
|
US7714025B2
(en)
*
|
2006-05-10 |
2010-05-11 |
Arizona Biomedical Research Commission |
Modified chalcone compounds as antimitotic agents
|
PL2079732T3
(pl)
|
2006-05-29 |
2012-05-31 |
High Point Pharmaceuticals Llc |
3-(1,3-benzodioksol-5-ylo)-6-(4-cyklopropylopiperazyn-1-ylo)-pirydazyna, jej sole i solwaty oraz jej zastosowanie jako antagonisty receptora histaminowego h3
|
WO2008008363A1
(fr)
|
2006-07-11 |
2008-01-17 |
Qps, Llc |
Compositions pharmaceutiques pour délivrance à libération prolongée de peptides
|
WO2008015099A2
(fr)
|
2006-07-31 |
2008-02-07 |
Novo Nordisk A/S |
Insulines pegylées à extensions
|
CN101541830A
(zh)
|
2006-09-22 |
2009-09-23 |
诺沃-诺迪斯克有限公司 |
蛋白酶抗性的胰岛素类似物
|
WO2008037735A1
(fr)
|
2006-09-27 |
2008-04-03 |
Novo Nordisk A/S |
Procédé de fabrication de polypeptides d'insuline mature
|
WO2008049711A1
(fr)
*
|
2006-10-27 |
2008-05-02 |
Novo Nordisk A/S |
Insuline à peptide ajouté
|
EP2152245B1
(fr)
|
2007-04-30 |
2015-12-02 |
Novo Nordisk A/S |
Procédé de déshydratation d'une composition de protéine, composition de protéine déshydratée et composition pharmaceutique contenant la protéine déshydratée
|
EP2514406A1
(fr)
|
2007-06-01 |
2012-10-24 |
Novo Nordisk A/S |
Préconcentrés spontanément dispersibles comprenant un médicament peptidique dans un support solide ou semi-solide
|
EP2164459A1
(fr)
|
2007-06-01 |
2010-03-24 |
Novo Nordisk A/S |
Compositions pharmaceutiques non aqueuses stables
|
ES2744384T3
(es)
|
2007-06-13 |
2020-02-24 |
Novo Nordisk As |
Formulación farmacéutica que comprende un derivado de insulina
|
EP2178909B1
(fr)
|
2007-08-13 |
2015-10-21 |
Novo Nordisk A/S |
Analogues de l'insuline à action rapide
|
KR101234540B1
(ko)
*
|
2007-10-16 |
2013-02-19 |
바이오콘 리미티드 |
경구 투여가능한 고형 약제학적 조성물 및 그 제조방법
|
WO2009060071A1
(fr)
*
|
2007-11-08 |
2009-05-14 |
Novo Nordisk A/S |
Dérivé de l'insuline
|
EP2058330A1
(fr)
*
|
2007-11-08 |
2009-05-13 |
Novo Nordisk A/S |
Dérivé d'insuline
|
CN107115523A
(zh)
|
2007-11-16 |
2017-09-01 |
诺沃—诺迪斯克有限公司 |
包含glp‑1肽或毒蜥外泌肽‑4和基础胰岛素肽的药物组合物
|
US20090175840A1
(en)
*
|
2008-01-04 |
2009-07-09 |
Biodel, Inc. |
Insulin formulations for insulin release as a function of tissue glucose levels
|
JP5762001B2
(ja)
|
2008-03-14 |
2015-08-12 |
ノボ・ノルデイスク・エー/エス |
プロテアーゼ安定化インスリンアナログ
|
US8691759B2
(en)
|
2008-03-18 |
2014-04-08 |
Novo Nordisk A/S |
Protease stabilized, acylated insulin analogues
|
TWI451876B
(zh)
|
2008-06-13 |
2014-09-11 |
Lilly Co Eli |
聚乙二醇化之離脯胰島素化合物
|
KR20110059602A
(ko)
|
2008-08-07 |
2011-06-02 |
바이오콘 리미티드 |
인슐린 화합물의 제조방법
|
BRPI0919946A2
(pt)
|
2008-10-30 |
2016-02-16 |
Novo Nordisk As |
tratamento de diabetes melito usando injeções de insulina com frequência de injeção menor que diariamente
|
KR20110088575A
(ko)
|
2008-11-21 |
2011-08-03 |
하이 포인트 파마슈티칼스, 엘엘씨 |
아다만틸 벤즈아미드 화합물
|
CA2750252A1
(fr)
|
2009-01-28 |
2010-08-05 |
Smartcells, Inc. |
Conjugues synthetiques et leurs utilisations
|
SG2014006597A
(en)
|
2009-01-28 |
2014-04-28 |
Smartcells Inc |
Conjugate based systems for controlled drug delivery
|
US9060927B2
(en)
*
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
JP2012520879A
(ja)
|
2009-03-20 |
2012-09-10 |
スマートセルズ・インコーポレイテツド |
末端官能基化コンジュゲートおよびその用途
|
US20120134977A1
(en)
|
2009-06-01 |
2012-05-31 |
Yeda Research And Development Co. Ltd. |
Prodrugs containing albumin binding probe
|
JP5892940B2
(ja)
|
2009-11-25 |
2016-03-23 |
アリスジェン ソシエテ アノニム |
クラウン化合物及び/又は対イオンと複合体化されたペプチドを含む粘膜送達組成物
|
EP2460527A1
(fr)
|
2010-01-21 |
2012-06-06 |
Sanofi |
Composition pharmaceutique pour le traitement d'un syndrome métabolique
|
AR081066A1
(es)
|
2010-04-02 |
2012-06-06 |
Hanmi Holdings Co Ltd |
Conjugado de insulina donde se usa un fragmento de inmunoglobulina
|
US9981017B2
(en)
|
2010-04-02 |
2018-05-29 |
Hanmi Science Co., Ltd. |
Insulin conjugate using an immunoglobulin fragment
|
AR080884A1
(es)
|
2010-04-14 |
2012-05-16 |
Sanofi Aventis |
Conjugados de insulina-sirna
|
CN107029212A
(zh)
*
|
2010-05-10 |
2017-08-11 |
诺沃—诺迪斯克有限公司 |
用于制备胰岛素‑锌复合物的方法
|
EP2627670A2
(fr)
*
|
2010-10-15 |
2013-08-21 |
Novo Nordisk A/S |
Nouveaux dérivés d'insuline à extrémité n modifiée
|
DK2632478T3
(da)
|
2010-10-27 |
2019-10-07 |
Novo Nordisk As |
Behandling af diabetes melitus under anvendelse af insulinindsprøjtninger indgivet med varierende indsprøjtningsintervaller
|
EP2654794B8
(fr)
|
2010-12-22 |
2020-04-22 |
Baxalta GmbH |
Matériels et méthodes pour la conjugaison d'un dérivé d'acide gras soluble dans l'eau à une protéine
|
KR20140043709A
(ko)
|
2011-01-20 |
2014-04-10 |
질랜드 파마 에이/에스 |
아실화 글루카곤 유사체와 인슐린 유사체의 조합
|
US10130684B2
(en)
|
2011-02-03 |
2018-11-20 |
Pharmedica Ltd. |
Oral dissolving films for insulin administration, for treating diabetes
|
US9480751B2
(en)
|
2011-04-11 |
2016-11-01 |
Yeda Research And Development Co. Ltd. |
Albumin binding probes and drug conjugates thereof
|
EP2548570A1
(fr)
|
2011-07-19 |
2013-01-23 |
Sanofi |
Composition pharmaceutique pour le traitement d'un syndrome métabolique
|
CN102504022A
(zh)
*
|
2011-11-30 |
2012-06-20 |
苏州元基生物技术有限公司 |
含有保护赖氨酸的胰岛素原及使用其制备胰岛素的方法
|
EP2784085A4
(fr)
*
|
2011-12-15 |
2015-07-08 |
Shanghai Hengrui Pharm Co Ltd |
Analogue d'insuline humaine et son dérivé acylé
|
BR112014025132A2
(pt)
|
2012-04-11 |
2017-07-11 |
Novo Nordisk As |
formulações de insulina
|
JP6262206B2
(ja)
|
2012-05-01 |
2018-01-17 |
ノヴォ ノルディスク アー/エス |
医薬組成物
|
JP6735561B2
(ja)
|
2012-12-03 |
2020-08-05 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
O−グリコシル化カルボキシ末端部分(ctp)ペプチド系のインスリンおよびインスリン類似体
|
US10137172B2
(en)
|
2013-04-30 |
2018-11-27 |
Novo Nordisk A/S |
Administration regime
|
US10286078B2
(en)
|
2013-09-13 |
2019-05-14 |
The California Institute For Biomedical Research |
Modified therapeutic agents and compositions thereof
|
BR112016007166A2
(pt)
|
2013-10-07 |
2017-09-12 |
Novo Nordisk As |
derivado de um análogo de insulina
|
US10039809B2
(en)
|
2013-12-18 |
2018-08-07 |
The California Institute For Biomedical Research |
Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof
|
AR099569A1
(es)
|
2014-02-28 |
2016-08-03 |
Novo Nordisk As |
Derivados de insulina y los usos médicos de estos
|
US9656017B2
(en)
|
2014-06-20 |
2017-05-23 |
Howard E. Greene |
Infusion delivery devices and methods
|
US20190000928A1
(en)
|
2015-06-17 |
2019-01-03 |
The California Institute For Biomedical Research |
Modified therapeutic agents and compositions thereof
|
US11352406B2
(en)
|
2015-08-25 |
2022-06-07 |
Novo Nordisk A/S |
Insulin derivatives and the medical uses hereof
|
US10815287B2
(en)
|
2016-08-02 |
2020-10-27 |
Jiangsu Hengrui Medicine Co., Ltd. |
Acylated derivative of human insulin or analogue thereof
|
JP2020504714A
(ja)
|
2016-12-05 |
2020-02-13 |
ニューリタス リミテッド |
ペプチドwkdeagkplvkを含む組成物
|
EP3329930A1
(fr)
|
2016-12-05 |
2018-06-06 |
Nuritas Limited |
Compositions pharmaceutiques
|
JP6690062B2
(ja)
|
2016-12-16 |
2020-04-28 |
ノヴォ ノルディスク アー/エス |
インスリン含有医薬組成物
|
AU2018321157B2
(en)
|
2017-08-24 |
2024-03-28 |
Novo Nordisk A/S |
GLP-1 compositions and uses thereof
|
JP2020535199A
(ja)
*
|
2017-09-29 |
2020-12-03 |
ハンミ ファーマシューティカル カンパニー リミテッド |
効力が向上した持続性タンパク質結合体
|
WO2019125878A1
(fr)
|
2017-12-18 |
2019-06-27 |
Merck Sharp & Dohme Corp. |
Systèmes à base de conjugués pour l'administration contrôlée d'insuline
|
WO2019125879A2
(fr)
|
2017-12-18 |
2019-06-27 |
Merck Sharp & Dohme Corp. |
Systèmes à base de conjugués pour l'administration contrôlée d'insuline
|
US20210032307A1
(en)
|
2018-02-09 |
2021-02-04 |
Jiangsu Hengrui Medicine Co., Ltd. |
Codon optimized precursor gene and signal peptide gene of human insulin analogue
|
AU2019272401A1
(en)
|
2018-05-24 |
2021-01-14 |
Jiangsu Hengrui Medicine Co., Ltd. |
Method for preparing precursor of recombinant human insulin or analogue thereof
|
US10335464B1
(en)
|
2018-06-26 |
2019-07-02 |
Novo Nordisk A/S |
Device for titrating basal insulin
|
KR20200017078A
(ko)
|
2018-08-08 |
2020-02-18 |
주식회사 대웅제약 |
지속형 인슐린 아날로그 및 그 복합체
|
WO2020120479A1
(fr)
|
2018-12-11 |
2020-06-18 |
Sanofi |
Liant peptidique
|
KR20200080747A
(ko)
|
2018-12-27 |
2020-07-07 |
주식회사 폴루스 |
인슐린 전구체의 인슐린 효소 전환용 조성물 및 이를 이용하여 인슐린 전구체를 인슐린으로 전환하는 방법
|
KR20200080748A
(ko)
|
2018-12-27 |
2020-07-07 |
주식회사 폴루스 |
음이온 교환 크로마토그래피를 이용한 인슐린 전구체의 정제방법
|
CN111909255A
(zh)
*
|
2019-05-10 |
2020-11-10 |
宁波鲲鹏生物科技有限公司 |
胰岛素衍生物及其制备方法
|
TW202120536A
(zh)
|
2019-07-31 |
2021-06-01 |
美商美國禮來大藥廠 |
鬆弛素(relaxin)類似物及其使用方法
|
MX2022006251A
(es)
|
2019-12-11 |
2022-06-22 |
Novo Nordisk As |
Analogos de insulina novedosos y usos de estos.
|
CA3166496A1
(fr)
|
2019-12-30 |
2021-07-08 |
Gan & Lee Pharmaceuticals Co., Ltd. |
Compose glp-1 a action prolongee
|
AU2020417892A1
(en)
|
2019-12-30 |
2022-08-25 |
Gan & Lee Pharmaceuticals Co., Ltd. |
Insulin derivative
|
IL294520A
(en)
|
2020-02-18 |
2022-09-01 |
Novo Nordisk As |
Pharmaceutical formulations
|
AU2021247169A1
(en)
|
2020-03-31 |
2022-10-20 |
Protomer Technologies Inc. |
Conjugates for selective responsiveness to vicinal diols
|
AU2021382599A1
(en)
|
2020-11-19 |
2023-06-22 |
Protomer Technologies Inc. |
Aromatic boron-containing compounds and insulin analogs
|
EP4299057A1
(fr)
|
2022-06-30 |
2024-01-03 |
Adocia |
Compositions solides comportant un peptide ou une protéine et un acide aminé acylé
|
EP4180060A1
(fr)
|
2021-11-15 |
2023-05-17 |
Adocia |
Compositions solides comportant un peptide ou une protéine et un acide aminé acylé
|
WO2023084118A1
(fr)
|
2021-11-15 |
2023-05-19 |
Adocia |
Compositions solides comprenant un peptide ou une protéine et un acide aminé acylé
|
EP4299071A1
(fr)
|
2022-07-01 |
2024-01-03 |
Adocia |
Compositions comprenant un peptide ou une protéine et un acide aminé acylé
|
WO2024051787A1
(fr)
*
|
2022-09-09 |
2024-03-14 |
北京惠之衡生物科技有限公司 |
Dérivé d'insuline acylé à action prolongée et son utilisation
|